Apeiron Capital Investment Corp. financial data

Industry
Biological Products, (No Diagnostic Substances)
Location
175 Federal Street, Suite 875, Boston, MA
State of incorporation
DE
Fiscal year end
December 31

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 66.7 %
Debt-to-equity -112 %
Return On Equity -20.3 % +75.5%
Return On Assets 2.24 %

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 172M USD

Income Statement

Label TTM Value / Value Unit Change %
Operating Income (Loss) -1.86M USD -292%
Nonoperating Income (Expense) 4.66M USD -67%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 2.8M USD -82.5%
Income Tax Expense (Benefit) 32.7K USD
Net Income (Loss) Attributable to Parent 2.17M USD -62.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 558K USD
Assets, Current 755K USD -13.3%
Assets 16.5M USD -90.7%
Accrued Liabilities, Current 1.38M USD +419%
Liabilities, Current 2M USD
Liabilities 11.9M USD -3.6%
Retained Earnings (Accumulated Deficit) -11M USD
Stockholders' Equity Attributable to Parent -11M USD +3.15%
Liabilities and Equity 16.5M USD -90.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -298K USD -178%
Net Cash Provided by (Used in) Financing Activities -717K USD
Net Cash Provided by (Used in) Investing Activities 551K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -463K USD -332%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 631K USD -2.07%
Deferred Tax Assets, Valuation Allowance 347K USD +611%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 347K USD +611%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1M shares 0%
Unrecognized Tax Benefits 0 USD
Preferred Stock, Shares Outstanding 0 shares
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%